Cargando…

Impact of Physical Activity on Oxidative Stress Markers in Patients with Metastatic Breast Cancer

PURPOSE: Regular physical activity (PA) can affect oxidative stress, known to be involved in carcinogenesis. The objective of this study was to evaluate the associations between a six-month PA intervention and oxidative stress biomarkers, PA, and clinical outcomes in patients with metastatic breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delrieu, Lidia, Touillaud, Marina, Pérol, Olivia, Morelle, Magali, Martin, Agnès, Friedenreich, Christine M., Mury, Pauline, Dufresne, Armelle, Bachelot, Thomas, Heudel, Pierre-Etienne, Fervers, Béatrice, Trédan, Olivier, Pialoux, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302399/ https://www.ncbi.nlm.nih.gov/pubmed/34326920 http://dx.doi.org/10.1155/2021/6694594

Ejemplares similares

Feasibility and Health Benefits of an Individualized Physical Activity Intervention in Women With Metastatic Breast Cancer: Intervention Study
por: Delrieu, Lidia, et al.
Publicado: (2020)

Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial
por: Delrieu, Lidia, et al.
Publicado: (2021)

A Personalized Physical Activity Program With Activity Trackers and a Mobile Phone App for Patients With Metastatic Breast Cancer: Protocol for a Single-Arm Feasibility Trial
por: Delrieu, Lidia, et al.
Publicado: (2018)

Effects of an Exercise and Nutritional Intervention on Circulating Biomarkers and Metabolomic Profiling During Adjuvant Treatment for Localized Breast Cancer: Results From the PASAPAS Feasibility Randomized Controlled Trial
por: Febvey-Combes, Olivia, et al.
Publicado: (2021)

Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trial
por: Delrieu, Lidia, et al.
Publicado: (2020)

Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trial
por: Gouez, Manon, et al.
Publicado: (2022)

Connected device and therapeutic patient education to promote physical activity among women with localised breast cancer (DISCO trial): protocol for a multicentre 2×2 factorial randomised controlled trial
por: Touillaud, Marina, et al.
Publicado: (2021)

A Digital Solution for an Advanced Breast Tumor Board: Pilot Application Cocreation and Implementation Study
por: Hodroj, Khalil, et al.
Publicado: (2023)

Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer
por: Delrieu, Lidia, et al.
Publicado: (2020)

Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial
por: Bonnet, Elise, et al.
Publicado: (2022)

Patterns of Sequelae in Women with a History of Localized Breast Cancer: Results from the French VICAN Survey
por: Delrieu, Lidia, et al.
Publicado: (2021)

P02-16 Implementation of a program based on adapted physical activity and recommendations for second cancers prevention for adolescents and young adults with cancer: PREVAPAJA study
por: Mongondry, Rodolf, et al.
Publicado: (2022)

Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study
por: Mery, Benoîte, et al.
Publicado: (2023)

Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial
por: Arnaud-Coffin, Patrick, et al.
Publicado: (2020)

Association between Body Mass Index and Survival Outcome in Metastatic Cancer Patients Treated by Immunotherapy: Analysis of a French Retrospective Cohort
por: Collet, Laetitia, et al.
Publicado: (2021)

Design of a randomised controlled trial of adapted physical activity during adjuvant treatment for localised breast cancer: the PASAPAS feasibility study
por: Touillaud, M, et al.
Publicado: (2013)

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients
por: Manuel, Manuarii, et al.
Publicado: (2012)

Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival
por: Rochefort, Pauline, et al.
Publicado: (2017)

Frequency of Asbestos Exposure and Histological Subtype of Ovarian Carcinoma
por: Vidican, Pauline, et al.
Publicado: (2022)

Effectiveness of an individualized home-based physical activity program in surgery-free non-endarterectomized asymptomatic stroke patients: a study protocol for the PACAPh interventional randomized trial
por: Mura, Mathilde, et al.
Publicado: (2022)

Correction to: Effectiveness of an individualized home-based physical activity program in surgery-free non-endarterectomized asymptomatic stroke patients: a study protocol for the PACAPh interventional randomized trial
por: Mura, Mathilde, et al.
Publicado: (2022)

Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
por: Heudel, Pierre, et al.
Publicado: (2022)

Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer
por: Belbaraka, Rhizlane, et al.
Publicado: (2010)

Systematic Screening for Occupational Exposures in Lung Cancer Patients: A Prospective French Cohort
por: Pérol, Olivia, et al.
Publicado: (2018)

Validation of prognostic scores for survival in cancer patients beyond first-line therapy
por: Trédan, Olivier, et al.
Publicado: (2011)

Individualised physical activity programme in patients over 65 years with haematological malignancies (OCAPI): protocol for a single-arm feasibility trial
por: Fournier, Baptiste, et al.
Publicado: (2021)

Prooxidant/Antioxidant Balance in Hypoxia: A Cross-Over Study on Normobaric vs. Hypobaric “Live High-Train Low”
por: Debevec, Tadej, et al.
Publicado: (2015)

Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology
por: Dufresne, Armelle, et al.
Publicado: (2014)

Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel, Pierre, et al.
Publicado: (2012)

Studying the impact of early life exposures to pesticides on the risk of testicular germ cell tumors during adulthood (TESTIS project): study protocol
por: Béranger, Rémi, et al.
Publicado: (2014)

Feasibility Study to Assess the Impact of a Lifestyle Intervention during Colorectal Cancer Screening in France
por: Huybrechts, Inge, et al.
Publicado: (2021)

Higher Daily Physical Activity Level Is Associated with Lower RBC Aggregation in Carotid Artery Disease Patients at High Risk of Stroke
por: Mury, Pauline, et al.
Publicado: (2017)

Outcome of recurrent and metastatic small cell carcinoma of the bladder
por: Ismaili, Nabil, et al.
Publicado: (2009)

Targeting AKT in ER-Positive HER2-Negative Metastatic Breast Cancer: From Molecular Promises to Real Life Pitfalls?
por: Mery, Benoîte, et al.
Publicado: (2021)

Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer
por: Cassier, Philippe A, et al.
Publicado: (2011)

Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay
por: Verronèse, E., et al.
Publicado: (2015)

Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer
por: Eve, Louisane, et al.
Publicado: (2020)

MAINTENANCE HORMONAL TREATMENT IMPROVES PROGRESSION FREE SURVIVAL AFTER A FIRST LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST CANCER
por: Dufresne, Armelle, et al.
Publicado: (2008)

Sickle Cell Trait Worsens Oxidative Stress, Abnormal Blood Rheology, and Vascular Dysfunction in Type 2 Diabetes
por: Diaw, Mor, et al.
Publicado: (2015)

TP53 Mutation as a Prognostic and Predictive Marker in Sarcoma: Pooled Analysis of MOSCATO and ProfiLER Precision Medicine Trials
por: Nassif, Elise F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9iljfa77gnsq7hkf0ibeprathu